Patients missing out on vital statins after acute coronary syndrome

Intensive lipid-lowering therapy could reduce their risk of another event, say researchers

Almost half of patients discharged from hospital after an acute coronary syndrome are missing out on intensive lipid-lowering therapy that could reduce their risk of another event, Australian researchers say.


Analysis of data from 3400 patients enrolled in the CONCORDANCE registry, which covers 42 hospitals, shows that 45% of patients admitted for an acute coronary syndrome (ACS) were not receiving high-intensity statins or ezetimibe post-discharge.

One-quarter of patients were shown to be receiving some form of lipid-lowering therapy other than the recommended